Please log in to view this page
Username
Password
Primary Objective To obtain sputum, serum, urine, and peripheral blood mononuclear cells (PBMCs) for central TB biorepository...
PK, safety and acceptability data and practical guidance on the optimal dosing of new more child-friendly formulations of...
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
Purpose: The C-TRIUMPH study has identified 20 household contacts (HHC), who have progressed to active TB from its HHCs cohort...
